David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$9.63B |
| 2 |
Amazon
AMZN
|
+$1.56B |
| 3 |
NVIDIA
NVDA
|
+$1.1B |
| 4 |
Meta Platforms (Facebook)
META
|
+$924M |
| 5 |
SPCX
SpaceX
SPCX
|
+$907M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$2.17B |
| 2 |
Broadcom
AVGO
|
+$1.53B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
TSMC
TSM
|
+$928M |
| 5 |
Texas Instruments
TXN
|
+$904M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.78% |
| 2 | Financials | 8.35% |
| 3 | Healthcare | 7.91% |
| 4 | Consumer Discretionary | 7.83% |
| 5 | Industrials | 7.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1376
PUT
AXT Inc
AXTI
$4.29B
| $15.8M | 0.01% |
219,700
+84,700
| +63% | +$7.63M |
|
1377
Prothena Corp
PRTA
$482M
| $15.8M | 0.01% |
1,611,457
-151,890
| -9% | -$1.5M |
|
|
LAC
1378
Lithium Americas
LAC
$1.13B
| $15.7M | 0.01% |
4,090,933
-4,619,375
| -53% | -$22M |
|
1379
Levi Strauss
LEVI
$8.36B
| $15.7M | 0.01% |
632,872
-705,768
| -53% | -$15.9M |
|
1380
Warner Music
WMG
$14.5B
| $15.7M | 0.01% |
579,866
+176,667
| +44% | +$5.25M |
|
1381
Cirrus Logic
CRUS
$5.6B
| $15.7M | 0.01% |
105,639
+43,481
| +70% | +$7.12M |
|
1382
CALL
DraftKings
DKNG
$12.9B
| $15.6M | 0.01% |
619,300
+35,000
| +6% | +$863K |
|
1383
Smith & Nephew
SNN
$12.4B
| $15.6M | 0.01% |
542,865
-368,862
| -40% | -$11.5M |
|
1384
Diebold Nixdorf
DBD
$2.34B
| $15.6M | 0.01% |
183,782
+27,882
| +18% | +$2.24M |
|
1385
Rush Street Interactive
RSI
$3.05B
| $15.6M | 0.01% |
525,319
-862,831
| -62% | -$22.7M |
|
1386
MetLife
MET
$61.1B
| $15.6M | 0.01% |
184,326
+117,540
| +176% | +$9.48M |
|
1387
First Trust Nasdaq Semiconductor ETF
FTXL
$1.24B
| $15.6M | 0.01% |
54,643
+40,129
| +276% | +$9.28M |
|
1388
FNB Corp
FNB
$6.58B
| $15.6M | 0.01% |
815,740
+780,640
| +2,224% | +$13.9M |
|
1389
Enliven Therapeutics
ELVN
$4.48B
| $15.5M | 0.01% |
305,703
+112,172
| +58% | +$4.76M |
|
1390
PUT
Clorox
CLX
$13B
| $15.5M | 0.01% |
162,500
-54,700
| -25% | -$5.25M |
|
1391
Equinox Gold
EQX
$16.1B
| $15.5M | 0.01% |
1,594,943
-915,856
| -36% | -$11.8M |
|
|
XYZ
1392
Block Inc
XYZ
$48.9B
| $15.5M | 0.01% |
204,014
+131,064
| +180% | +$9.21M |
|
1393
Savara
SVRA
$1.14B
| $15.5M | 0.01% |
2,514,998
+403,116
| +19% | +$2.16M |
|
1394
NovoCure
NVCR
$1.95B
| $15.5M | 0.01% |
1,022,480
+375,418
| +58% | +$5.68M |
|
1395
AGNC Investment
AGNC
$13B
| $15.5M | 0.01% |
1,419,557
-10,689
| -0.7% | -$113K |
|
1396
Leonardo DRS
DRS
$10.4B
| $15.5M | 0.01% |
362,203
-149,556
| -29% | -$6.65M |
|
1397
CALL
McKesson
MCK
$102B
| $15.4M | 0.01% |
20,400
-1,000
| -5% | -$793K |
|
|
NVMI
1398
PUT
Nova
NVMI
$11.5B
| $15.4M | 0.01% |
28,300
+5,100
| +22% | +$2.62M |
|
1399
CALL
Mastercard
MA
$525B
| $15.4M | 0.01% |
+29,900
| New | +$14.9M |
|
1400
BorgWarner
BWA
$13.1B
| $15.3M | 0.01% |
230,978
-846,542
| -79% | -$53.6M |
|
Similar funds
David Shaw's Q2 2026 Portfolio in Review
As of Q2 2026, David Shaw held 5,360 positions worth $210B, up 26% from $166B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
David Shaw deployed $7.01B of net new capital in Q2 2026, opening 872 new positions and adding to 1,718 existing holdings. Its largest new stake was SpaceX: 5,340,000 shares worth $912M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Micron Technology, an estimated $2.17B trimmed.
- David Shaw's largest Q2 2026 buy was SpaceX: 5,340,000 shares worth $912M.
- David Shaw added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $9.63B increase.
- David Shaw's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $2.17B.
- David Shaw fully exited Automatic Data Processing in Q2 2026, selling an estimated $241M.
- David Shaw's ten largest holdings make up 15% of its $210B portfolio in Q2 2026.
- David Shaw opened 872 new positions and closed 527 in Q2 2026.
- David Shaw's portfolio value rose 26% quarter-over-quarter to $210B.
Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.